Previous genetic association studies suggested that patients with CPA might produce lower levels of IL-10 and have ongoing or higher expression of IL-1b and IL-6 leading to a pro-inflammatory response and disease progression (Sambatakou et al., 2006; Smith et al., 2014). The gene discussed is IL1B; the disease is congenital primary aphakia.